Arylfurans as potential Trypanosoma cruzi trypanothione reductase inhibitors

被引:37
|
作者
de Oliveira, RB
Vaz, ABM
Alves, RO
Liarte, DB
Donnici, CL
Romanha, AJ
Zani, CL
机构
[1] Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Quim Prod Nat, BR-30190002 Belo Horizonte, MG, Brazil
[2] Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Parasitol Celular & Mol, BR-30190002 Belo Horizonte, MG, Brazil
[3] Univ Fed Minas Gerais, Inst Ciencias Exatas, NEQUIM, Dept Quim, Belo Horizonte, MG, Brazil
来源
MEMORIAS DO INSTITUTO OSWALDO CRUZ | 2006年 / 101卷 / 02期
关键词
tropical diseases; Chagas disease; arylfurans; trypanothione reductase;
D O I
10.1590/S0074-02762006000200009
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
The natural lignans veraguensin and grandisin have been reported to be active against Trypanosoma cruzi bloodstream forms. Aiming at the total synthesis of these and related compounds, we prepared three 2-arylfurans and eight 2,5-diary rans. They were evaluated for their potential as T. cruzi trypanothione reductase (TR) inhibitors as well against the parasite intracellular (amastigote) and bloodstream (trypomastigote) forms. Compound 12 was the most effective against TR with an IC50 of 48.5 mu M while 7 and 14 were active against amastigotes, inhibiting the parasite development by 60% at 20 mu g/ml (59 and 90 mu M, respectively). On the other hand, none of the compounds was significantly active against the parasite bloodstream forms even at 250 mu g/ml (0.6-1.5 mM).
引用
收藏
页码:169 / 173
页数:5
相关论文
共 50 条
  • [21] In silico identification of α-bisabolol and letestuianin C as potential inhibitors of Trypanosoma brucei trypanothione reductase
    Nketia, Prisca Baah
    Gasu, Edward Ntim
    Mensah, Jehoshaphat Oppong
    Borquaye, Lawrence Sheringham
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024, 42 (16): : 8660 - 8672
  • [22] Trypanosoma cruzi dihydrofolate reductase inhibitors: A potential Chagas disease treatment
    Thao Nguyen
    Schromann, Norbert
    Chattopadhyay, Debasish
    Velu, Sadanandan
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [23] N-(2-naphthylmethyl) substituted polyamine derivatives as inhibitors of Trypanosoma cruzi trypanothione reductase.
    Deluca, J
    Rose, J
    Kobaslija, M
    O'Sullivan, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U377 - U377
  • [24] Extrachromosomal, homologous expression of trypanothione reductase and its complementary mRNA in Trypanosoma cruzi
    Tovar, J
    Fairlamb, AH
    NUCLEIC ACIDS RESEARCH, 1996, 24 (15) : 2942 - 2949
  • [25] CLONING, SEQUENCING, OVERPRODUCTION AND PURIFICATION OF TRYPANOTHIONE REDUCTASE FROM TRYPANOSOMA-CRUZI
    SULLIVAN, FX
    WALSH, CT
    MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1991, 44 (01) : 145 - 147
  • [26] Novel inhibitors of Trypanosoma cruzi dihydrofolate reductase
    Zuccotto, F
    Zvelebil, M
    Brun, R
    Chowdhury, SF
    Di Lucrezia, R
    Leal, I
    Maes, L
    Ruiz-Perez, LM
    Pacanowska, DG
    Gilbert, IH
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2001, 36 (05) : 395 - 405
  • [27] Analysis of polymorphisms in the trypanothione reductase and cruzipain genes in Colombian strains of Trypanosoma cruzi
    Rojas, Winston
    Caro, Maria Antonieta
    Lopera, Juan Guillermo
    Triana, Omar
    Dib, Juan Carlos
    Bedoya, Gabriel
    BIOMEDICA, 2007, 27 : 50 - 63
  • [28] Crystal structure of the Trypanosoma cruzi trypanothione reductase-mepacrine complex.
    Jacoby, EM
    Schlichting, I
    Barbe, J
    KrauthSiegel, RL
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 1996, 1 (06) : A22 - A23
  • [29] TRYPANOTHIONE REDUCTASE FROM TRYPANOSOMA-CRUZI - PURIFICATION AND CHARACTERIZATION OF THE CRYSTALLINE ENZYME
    KRAUTHSIEGEL, RL
    ENDERS, B
    HENDERSON, GB
    FAIRLAMB, AH
    SCHIRMER, RH
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1987, 164 (01): : 123 - 128
  • [30] Inhibitors of trypanothione reductase as potential antitrypanosomal drugs
    Chan, C
    Yin, H
    Garforth, J
    McKie, JH
    Jaouhari, RA
    Douglas, KT
    Fairlamb, AH
    Croft, SL
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1995, 23 (04) : S511 - S511